E
EUROAPI
CDMO · Paris, France
GMP
Overview
EUROAPI makes about 200 active ingredients and also offers contract development and manufacturing. Peptide and oligonucleotide work sits at its Frankfurt site, which draws on Sanofi's roughly 45 years of peptide experience and runs solid-phase synthesis from lab scale to cGMP production. The company says the Frankfurt site is regularly inspected by the FDA and other agencies. In 2022 it announced an €18 million investment to reach 500 kg a year of peptide and oligonucleotide capacity in Frankfurt.
Capabilities
- Solid-phase peptide synthesis
- cGMP peptide API manufacture
- Process development and scale-up
- Oligonucleotide manufacture
- Regulatory and CMC support
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |